Last 13.85 NOK
Change Today -0.80 / -5.46%
Volume 57.3K
NATTO On Other Exchanges
Symbol
Exchange
Berlin
As of 10:25 AM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

nattopharma asa (NATTO) Snapshot

Open
14.90 NOK
Previous Close
14.65 NOK
Day High
15.00 NOK
Day Low
13.50 NOK
52 Week High
07/2/14 - 22.50 NOK
52 Week Low
09/26/13 - 11.90 NOK
Market Cap
191.5M
Average Volume 10 Days
45.0K
EPS TTM
-0.37 NOK
Shares Outstanding
13.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NATTOPHARMA ASA (NATTO)

Related News

No related news articles were found.

nattopharma asa (NATTO) Related Businessweek News

No Related Businessweek News Found

nattopharma asa (NATTO) Details

NattoPharma ASA develops, distributes, and sells nutritional and pharmacy products, and provides associated services. The company offers MenaQ7 that provides vitamin K2 as a fermentation extract containing the menaquinone-7 for bone and cardiovascular health. It is also used as dietary supplements, as well as used in food supplements and fortified foods. The company has a research and development agreement with VitaK BV. NattoPharma ASA was founded in 2004 and is headquartered in Høvik, Norway.

Founded in 2004

nattopharma asa (NATTO) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: 70.0K NOK
Chief Financial Officer
Total Annual Compensation: 768.0K NOK
Senior Vice President Sales & Marketing Europ...
Total Annual Compensation: 718.0K NOK
Marketing Manager
Total Annual Compensation: 388.0K NOK
Compensation as of Fiscal Year 2012.

nattopharma asa (NATTO) Key Developments

NattoPharma ASA Signs Exclusive Distribution Agreement with Glanbia Nutritionals

Nattopharma ASA announced its newly formed exclusive distribution agreement with Glanbia Nutritionals, whereby NattoPharma's new ingredient, MenaQ7® PURE, a first-in-class nature-identical synthetic vitamin K2 as menaquinone-7 (MK-7), will be distributed throughout the United States and Canada by Glanbia Nutritionals, a leader in innovative premixes for supplements and functional foods and beverages. MenaQ7® PURE was innovated by NattoPharma to serve the dietary supplement, and food and beverage industries that require purity of ingredients that deliver more physical economy during manufacturing.

NattoPharma ASA, Q2 2014 Earnings Call, Aug 27, 2014

NattoPharma ASA, Q2 2014 Earnings Call, Aug 27, 2014

NattoPharma ASA Terminates Market Making Agreement with Norne Securities

NattoPharma ASA has terminated the market making agreement with Norne Securities AS. The last day of participation will be 12 August 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NATTO:NO 13.85 NOK -0.80

NATTO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NATTO.
View Industry Companies
 

Industry Analysis

NATTO

Industry Average

Valuation NATTO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.5x
Price/Book 2.4x
Price/Cash Flow 2,238.6x
TEV/Sales 10.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NATTOPHARMA ASA, please visit www.nattopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.